Business
Amwell is an enterprise platform and software company enabling hybrid care across in-person, virtual, and automated settings for health plans, providers, and innovators.
Amwell revenue fell 2.0% to $249.3M, the net loss narrowed to $95.7M, and free cash flow remained negative.
The read at a glance✓ Audited against SEC data
- Business mix — Hybrid care software platformNote
- Revenue — Revenue fell 2.0% to $249.3MWatch
- Profitability — Net loss narrowed 54.0%Note
- Cash — Free cash flow was -$66.0MWatch
- Balance sheet — Equity fell 22.7%Watch
- Insiders — 0 buys / 21 sellsWatch
- Accounting — Altman-Z distress; EQ safeWatch
Where the revenue comes from
Fiscal 2025, as American Well Corp reports it. History and quarterly detail are in the app.
- Platform Subscription$132.4M
- Visits$94.3M
- Others$22.6M
Leadership changes
From American Well Corp's own filings, the day they're filed.
- Mark Hirschhorn · Chief Operating Officer · appointmenteff. 2024-12-17
- Mark Hirschhorn · CFO · appointmenteff. 2024-10-21
- Robert Shepardson · Chief Financial Officer · departureeff. 2024-10-18
Latest filings
- 8-K · Company announcement2026-08-04
- 10-Q · Quarterly report2026-08-04
- 8-K · Company announcement2026-07-21
- 8-K · Company announcement2026-07-14
- 8-K · Company announcement2026-06-22
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about American Well Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.